Get started

CNTB

Potential break through $3 scenario for CNTBAfter the good news this morning, the CNTB just got a big dip from one of the whales with weak resistance buyback force resulting in a sum of 3mil shares exchanged between buy and sale leading to a current ~$1.4. However, I noticed a similar pattern around October time where a bullish push for $1.2 and a big dip after that down to $0.79. This dip is almost 36% dip while we are experiencing $1.4 from $2.89 which is dip %51. This dip is much larger than the previous dip with potentially an uptrend bullish run for CNTB for the next 1 month run to above $3. This is a bullish scenario for the CNTB and hopefully, we will see the result of the fight between the bull and the bear! This is not financial advice but my update views on CNTB's position after recent good news!
NASDAQ:CNTBLong
by Hamahamieng
New long hold for good startup Biopharma companyWithout looking at the news, the CNTB should have gone down to get more air and stay around the $1.6 zone to be attractive. However, the new news regarding Simcere obtained the exclusive deal with CNTB regarding phase 3 drug rademikibart providing CNTB immediate big funding ($21M-$121M). This may signal a very bullish run if the market receives this news as excitement. The CNTB is still able to develop and commercialize rademikibart elsewhere aside from the greater China region (China, Hong Kong, Taiwan, Macau). We detect here a Cup and handle patterns and suspect there would be a breakthrough ceiling at $2.83 after rallying around $2.5. This is not financial advice but my view on CNTB at the current time!
NASDAQ:CNTBLong
by Haizsama
1